PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Structure. Author manuscript; available in PMC Feb 28, 2008.
Published in final edited form as:
PMCID: PMC2258087
NIHMSID: NIHMS40908
Bifunctional NMN adenylyltransferase/ADP ribose pyrophosphatase: structure and function in bacterial NAD metabolism
Nian Huang,1 Leonardo Sorci,2 Xuejun Zhang,1 Chad Brautigan,1 Xiaoqing Li,2 Nadia Raffaelli,3 Giulio Magni,3 Nick V. Grishin,1,4 Andrei Osterman,2* and Hong Zhang1*
1 Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390
4 Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75390
2 The Burnham Institute for Medical Research, La Jolla, CA 92037
3 Instituto di Biotecnologie Biochimiche, Università Politecnica delle Marche, 60131 Ancona, Italy
*Corresponding authors. Hong Zhang, phone: 214-645-6372, fax: 214-645-5948, E-mail: zhang/at/chop.swmed.edu. Andrei Osterman, phone: 858-713-6296, fax: 858-713-9949, e-mail: osterman/at/burnham.org
These authors contributed equally to this work.
Bacterial NadM-Nudix is a bifunctional enzyme containing a nicotinamide mononucleotide (NMN) adenylyltransferase and an ADP-ribose pyrophosphatase domain. While most members of this enzyme family, such as that from a model cyanobacterium Synechocystis sp., are involved primarily in NAD savage/recycling pathways, its close homolog in a category A biodefense pathogen Francisella tularensis likely plays a central role in a recently discovered novel pathway of NAD de novo synthesis. The crystal structures of NadM-Nudix from both species, including their complexes with various ligands and catalytic metal ions, revealed detailed configurations of the substrate binding and catalytic sites in both domains. The structure of the N-terminal NadM domain may be exploited for designing new anti-tularemia therapeutics. The ADP-ribose binding site in the C-terminal Nudix domain is substantially different from that of E. coli ADP-ribose pyrophosphatase, and is more similar to human NUDT9. The latter observation provided new insights into the ligand binding mode of ADPR-gated Ca2+ channel TRPM2.
Nicotinamide adenine dinucleotides (NAD and NADP) are ubiquitous cofactors in hundreds of redox reactions in the cell and thus are essential for all living organisms. In addition to its fundamental redox functions, NAD also serves as a co-substrate in a number of reactions that deplete its cellular pool, such as NAD-dependent protein deacetylation by the members of broadly conserved CobB/Sirtuin family (Denu, 2005; Landry et al., 2000; Tsang and Escalante-Semerena, 1998), ADP-ribosylation of proteins (Burkle, 2001), and DNA repair by DNA ligase in bacteria (Wilkinson et al., 2001). Several strategies are used by nature for NAD production and for NAD homeostasis maintenance in the cell (Begley et al., 2001; Magni et al., 1999; Penfound and Foster, 1996). The de novo NAD biosynthesis routes generate NAD from either aspartate (in prokaryotes) or tryptophan (mostly in eukaryotes), while niacin (vitamin B3) or nicotinamide riboside (NmR, or V-factor) can be salvaged from either external sources or recycled intracellularly via NAD degradation and some of the NAD-consuming reactions mentioned above. As most bacterial species can not salvage NAD(P) or its phosphorylated precursors from the medium, the last steps of NAD biosynthesis have been recognized as potential targets for developing novel anti-infectious therapeutics (Gerdes et al., 2002; Osterman and Begley, 2007; Velu et al., 2003).
All routes that lead to NAD synthesis require an adenylation step that generates the adenylated dinucleotides (NAD or deamido-NAD, NaAD) from nicotinamide or nicotinic acid mononucleotide (NMN or NaMN, see Fig. 1A). Adenylyltransferases responsible for this central step of NAD biosynthesis, termed NMNATase (EC 2.7.7.1) or NaMNATase (EC 2.7.7.18) depending on their substrate specificity, occur in at least four distinct families within a common fold that belong to the “(H/T)IGH motif containing nucleotidyltransferase superfamily” (Bork et al., 1995; Magni et al., 2004). Members of NadD family, conserved in most bacteria, have a strong preference for NaMN over NMN substrate in keeping with their essential role in the conventional two-step synthesis of NAD from the NaMN precursor via deamido-NAD (NaAD) intermediate (Fig. 1, Begley et al., 2001). Distant NadD homologs present in all eukaryotes form a separate PNAT family, which display a dual specificity with almost equal catalytic efficiency for both physiological substrates NaMN and NMN (Magni et al., 2004). Both activities play important roles in NAD metabolism in eukaryotic cells, the former in de novo NAD synthesis via NaMN, and the latter in the salvage and recycling of amidated precursors, e.g. nicotinamide (Nm) and nicotinamide riboside (NmR), via NMN (Berger et al., 2005; Sorci et al., 2007). A distantly related NadR family with a strong preference for NMN over NaMN is present in a limited group of bacteria (mostly Enterobacteriaceae ). Most members of this family contain at least two domains with NMNATase and NmR kinase (NRK) activities, which, together with PnuC transporter, form a NmR salvage pathway (Foster et al., 1990; Kurnasov et al., 2002; Raffaelli et al., 1999b). Members of the last, so called NadM family, are present in all archaea, where they are likely involved in the main NAD synthesis pathways (Raffaelli et al., 1994; Raffaelli et al., 1997). Close NadM homologs are present in a limited number of diverse bacteria, where they are almost always fused with a C-terminal Nudix hydrolyase domain. Historically the first, and until recently, the only characterized member of bacterial NadM-Nudix subfamily was the enzyme from Synechocystis sp. (slr0878), which displays a strong preference for NMN over NaMN in the adenylyltransferase reaction, and an ADP-ribose pyrophosphatase (ADPRase) activity via its Nudix domain (Raffaelli et al., 1999a). In Synechocystis sp. as well as in most other NadM-Nudix harboring bacteria, the main housekeeping NadD enzymes are also present. In most of these species the NadM-Nudix enzymes, together with nicotinamide phosphoribosyltransferase (NMPRT, EC 2.4.2.12, encoded by nadV gene) comprise a nicotinamide salvage/recycling pathway (Gerdes et al., 2006). A remarkable exception to this rule has recently been established in Francisella tularensis, the causative agent for tularemia, where, due to the absence of gene nadD, the NMNATase domain of NadM-Nudix is proposed to play the indispensable central role in NAD synthesis (Fig. 1B. Sorci et al. submitted). In contrast to most other bacteria, F. tularensis is shown to implement a nonconventional NAD ynthesis pathway, where the NaMN precursor is first amidated to NMN by a distant homolog of NAD synthetase and then converted to NAD by NMNATase of NadM (Fig. 1B, Sorci et al., submitted). These observations indicate that the closely related bacterial NadM-Nudix proteins, represented by those from Synechocystis sp. and F. tularensis, play drastically different cellular functions. A comparative biochemical and structural characterization of these two proteins will not only enable a better understanding of their respective functions, but also provide a starting point for the development of NMNATase inhibitors as potential new therapeutics against tularemia.
Figure 1
Figure 1
Transformations catalyzed by the three families of bacterial pyridine nucleotide adenylyltransferases and their roles in NAD biosynthesis, salvage and recycling pathways
Currently, the crystal structures of several NaMNATase and NMNATase enzymes including their complexes with substrates or products have been reported. These include representatives of bacterial NadD (Han et al., 2006; Olland et al., 2002; Yoon et al., 2005; Zhang et al., 2002), eukaryotic PNAT (Garavaglia et al., 2002; Werner et al., 2002; Zhang et al., 2003; Zhou et al., 2002), NadR (Singh et al., 2002) and archaeal NadM families (D'Angelo et al., 2000; Saridakis et al., 2001; Saridakis and Pai, 2003). Prior to the current study, the bacterial NadM-Nudix subfamily remained the last group of NMNATases to be structurally characterized.
The C-terminal domain of bacterial NadM-Nudix protein belongs to a large superfamily of pyrophosphohydrolases that are generally involved in the hydrolysis of physiological nucleotide metabolites and potentially toxic nucleoside diphosphate derivatives (Bessman et al., 1996; Koonin, 1993). Members of Nudix hydrolyase superfamily occur in a broad range of species and as multiple paralogs with various substrate specificities. For example, at least 13 Nudix proteins are present in E. coli, 22 in human genome (McLennan, 2006), and 21 Nudix hydrolases were systematically characterized in the radiation-resistant organism Deinococcus radiodurans (Xu et al., 2001). So far, structures of several members of Nudix superfamily with ADPRase activity have been reported including a monofunctional NudF enzyme from several bacterial species (Gabelli et al., 2001; Gabelli et al., 2002; Kang et al., 2003; Yoshiba et al., 2004), human NUDT9 and NUDT5 (Shen et al., 2003; Zha et al., 2006). Catalytic mechanisms of several representative Nudix enzymes including ADPRase were studied in detail (Mildvan et al., 2005). Interestingly, the C-terminal domain of bacterial NadM-Nudix enzyme appears to be more closely related to its archaeal homologs and mammalian NUDT9, than to bacterial NudF.
Here we report the crystal structures of NadM-Nudix proteins from a model cyanobacterium Synechocystis sp. and a category A biodefense pathogen Francisella tularensis (syNadM-Nudix and ftNadM-Nudix, respectively). These structures, combined with preliminary mutagenesis results, suggest a potentially complex mechanism underlying the observed stringent substrate preference for NMN over NaMN in the NadM domain, which may involve several structural elements surrounding the pyridine binding site. They also revealed detailed configurations and substrate binding mode in the active site of the ADPRase domain providing new insight to the catalytic mechanism of this subfamily of Nudix hydrolases.
Kinetic characterization
Steady state kinetic parameters were determined for both enzymatic activities of purified recombinant ftNadM-Nudix and syNadM-Nudix – the adenylyltransferase activity toward NMN and NaMN, and the pyrophosphohydrolase activity toward ADPR substrate. In contrast to members of archaeal NadM family, which display dual specificity toward NMN and NaMN substrate (L. Sorci and A. Osterman, unpublished data), both ftNadM and syNadM show a strong preference for NMN vs deamidated NaMN substrate (Sorci, et al. 2007, submitted). A much higher catalytic NMNATase efficiency was observed for F. tularensis enzyme compared to Synechocystis sp. (kcat/Km of 82.6 vs. 5.2 s−1 mM−1), consistent with its unique essential role in NAD biosynthesis. The pyrophosphohydrolase activities of ftNadM-Nudix investigated in this study are similar to those reported previously for syNadM-Nudix (Raffaelli et al., 1999a). Like the Synechocystis sp. enzyme, ftNadM-Nudix strongly prefers ADP-ribose over other tested potential substrates of Nudix hydrolases, including NAD+, NaAD+, NADH, NADP+, NADPH, ADPR, cADPR, ADP-glucose, Ap2A, ATP, ADP, and dNTPs. Compared to ADP-ribose, no more than 0.5% conversion was observed under tested conditions for other substrates. The steady state kinetic constants of ftNadM-Nudix for ADP-ribose are kcat =3.6 ± 0.4 s−1 and Km=41± 10 μM.
Overall structure of bacterial NadM-Nudix
We have determined the crystal structures of NadM-Nudix from both F. tularensis and Synechocystis sp. The syNadM-Nudix structure was solved first using selenomethionyl MAD phasing method. This structure was refined to 2.6Å resolution and was found to be complexed with the co-purified NAD and pyrophosphate in the NadM-domain active site, and with ADPR substrate in the Nudix-domain (Fig. 2A and 2B). The structure of ftNadM-Nudix was subsequently solved at 2.3Å resolution by the molecular replacement method using syNadM-Nudix structure as the search model. Because ftNadM-Nudix crystals were grown in the presence of 0.2 M MgCl2, a metal ion cluster was observed in the active site of its Nudix-domain. In contrast to syNadM-Nudix, no other ligand was found in either NadM or Nudix active site of the native ftNadM-Nudix crystal structure. We then determined the co-crystal structure of ftNadM-Nudix complexed with the product AMP and Mn2+ ions in its Nudix active site and were able to accurately determine the metal ion positions (Fig. 2C).
Figure 2
Figure 2
Fo-Fc difference electron density maps of the bound substrate and product in syNadM-Nudix and ftNadM-Nudix active sites
The overall structures of ftNadM-Nudix and syNadM-Nudix are very similar with an average root mean square deviation (rmsd) between Cα positions to be 1.44 Å over the entire length of the protein. As expected, these proteins contain both NMNATase- and ADPRase- domains (Fig. 3A). Their NMNATase domain belongs to the large superfamily of (H/T)IGH motif containing nucleotidyltransferases and is most closely related to archaeal NadM with a sequence identity of ~25% and an average rmsd of 2.1Å to Methanococcus jannaschii NadM (D'Angelo et al., 2000). The overall structure of the ADPRase-domain is similar to other Nudix enzymes with known structures. However there are significant conformational differences between the ADPRase Nudix domain of NadM-Nudix and bacterial monofunctional ADPRase, which will be discussed in more detail later. The two domains are connected by a long α helix (α8) with ADPRase active site facing away from the NMNATase domain, while the NMNATase active site opens partially toward the ADPRase domain. A large cleft remains between the two domains that should allow the entry of the substrates to the NMNATase active site and the release of the reaction products. Since the relative positioning of the two domains in NadM-Nudix of different ligand-bound states are very similar, it would suggest that each domain functions independently. Indeed substrate and products of ADPRase activity (ADPR, AMP and ribose-5-P) do not exert any effect on the NMNATase activity of ftNadM-Nudix (data not shown). These data, along with the results of earlier biochemical experiments indicate that there is no interaction between the two catalytic sites (Raffaelli et al., 1999a).
Figure 3
Figure 3
Overall structure of bacterial NadM-Nudix
syNadM-Nudix forms hexamer in both crystal and solution (data not shown). Two types of dimer interfaces are observed in syNadM-Nudix crystal structures, one of which is also conserved in ftNadM-Nudix, which exists as dimer in both crystal and solution (data not shown). This dimer interface is formed primarily through ADPRase domain of each monomer (Fig. 3B), and has a surprisingly small contact area of only 6.4% of the total surface area of the protein (1036 Å2). In this dimer, residues from the second monomer also contribute to the binding of substrate ADP-ribose to the first monomer. We believe that this shared dimeric organization must be prevalent among bacterial NadM-Nudix proteins.
NMNATase active site
The NMNATase domain of bacterial NadM-Nudix protein contains a central five-strand parallel β-sheet and several surrounding helices, a fold typical of the (H/T)IGH motif containing nucleotidyltransferases (Bork et al., 1995). The sequence and structure of bacterial NadM-NMNATase domain are more similar to archaeal NadM (~25% sequence identity) than to the bacterial NaMNATase (~15% identity) encoded by gene nadD (Raffaelli et al., 1999a; Singh et al., 2002), suggesting that it is probably acquired from the ancient archaeal NadM family through horizontal gene transfer. The overall structures as well as the active site configurations between bacterial and archaeal NadM are very similar indicating that the two enzymes share similar substrate binding and catalytic mechanisms (Fig. 4A). Here the (H/T)IGH motif and the preceding glycine rich loop located between strand β1 and helix α1 are involved in binding ATP phosphates with the second histidine residue of the motif coordinating the transferring α-phosphate. The second nucleotidyltransferase signature motif “ISSTxxR” is located at the N-terminus of helix α6 and is involved in binding the β and γ phosphates and stabilizing the leaving pyrophosphate group (Saridakis and Pai, 2003).
Figure 4
Figure 4
Comparison of bacterial and archaeal NadM
There are, however, notable differences in the pyridine nucleotide binding sites of archaeal and bacterial NadM that may account for their different substrate specificities. First, substantial conformational differences are observed in the “pyridine recognition loop” region, as well as in helices α4, α5 and the loop connecting α5 and β4 (Fig. 4A). Most of these regions are in the proximity of the bound NAD molecule. Despite these conformational differences, examining the detailed protein-nicotinamide interactions revealed nearly identical binding mode in both archaeal and bacterial NadM enzymes (Fig. 4B). In both enzymes, the nicotinamide ring forms a stacking interaction with the side chain of a tryptophan residue (Trp88 of syNadM and Trp87 of mtNadM, respectively); its carboxyamide groups are hydrogen bonded to the main chain amide and carbonyl groups of a residue from the “pyridine recognition loop” (Trp81 of syNadM and I81 of mtNadM, respectively. Fig. 4B). The most noticeable difference between the pyridine binding sites in the archaeal and bacterial NadM appeared to be in the position of residue 85 of syNadM, where the amino group of nicotinamide is hydrogen bonded to the side chain of Asp85 (Fig. 4B). While an Asp or Glu residue is nearly universally conserved at this position in bacterial NadM, the corresponding residue in archaeal NadM proteins is Asn (or Ser and Thr in few cases. See Supplemental Fig. S1). It is thus tempting to speculate that a change of this residue to an acidic Asp or Glu would render the active site of bacterial NadM less favorable for binding the more acidic NaMN due to electrostatic repulsion. Preliminary results from a Glu84→Gln mutant of ftNadM showed that the mutant did not have an improved catalytic efficiency toward NaMN substrate (data not shown). Apparently other structural elements, in particular the backbone of Trp81 that interacts with the carboxyamide group of the substrate, may play an important role in defining the NMN specificity of the enzyme. An analogous case has been observed in human dual specificity PNAT enzymes, where the exocyclic carboxyamide or carboxylate group also forms hydrogen bonds with protein main chain groups. The dual specificity for both NMN and NaMN in human PNAT is believed to be achieved via slight movements of protein backbones and an active site water molecule (Zhou, et. al., 2002). In such cases, the protein structural flexibility or plasticity around the pyridine binding site may be essential for a more relaxed substrate specificity. Inspection of protein residues around the pyridine binding site in syNadM showed that the “pyridine recognition loop”, where Trp81 is located, is in close contact with residues from the C-terminal Nudix domain (Fig. 3A. See also Supplement Fig. S2). The movement of this loop may be limited due to these contacts. On the other hand, the pyridine nucleotide binding site in syNadM appears to be more confined than that in mtNadM (Fig. 4B), thus the movement of the pyridine nucleotide bound to bacterial NadM may also be more restricted. All these observations point to a more rigid pyridine nucleotide binding site in bacterial NadM, which may render the enzyme less adoptive to the deamidated substrate NaMN. Further mutagenesis, biochemical, and structural analysis of both archaeal and bacterial NadM enzymes will be needed to test the above hypothesis and identify all the important structural determinants for their distinct substrate specificities.
Similar to what has been observed in mtNadM crystal structure, syNadM-Nudix was also co-purified and co-crystallized with the reaction products, NAD and pyrophosphate (Fig. 2A). In comparison, no product was retained in the active site of the NMNATase domain of ftNadM-Nudix. Two regions of the NMNATase domain, residues 110–120 between strand β4 and β5 encompassing short helix α5 and residues 131–137 between strand β5 and helix α6, are highly flexible and adopt conformations that deviate from the ligand bound form of syNadM (Fig. 4B). In the structure of syNadM complexed with NAD, several residues from these regions interact with the bound ligand directly and form part of the active site of the enzyme. Because of the lack of substrate or product complex structures for ftNadM, at this point it is difficult to rationalize the large difference in the catalytic efficiencies between the two enzymes from Synechocystis sp. and F. tularensis. These differences are manifested at both overall turn-over rate and substrate affinity levels as reflected in the different kcat and Km values of the two enzymes. The observed catalytic efficiency of ftNadM is comparable to the efficiency of other housekeeping NaMN adenylyltransferases and therefore it is consistent with its proposed cellular function as a housekeeping enzyme in de novo NAD synthesis.
Structure of the ADPRase domain
The ADPRase domain of bacterial NadM-Nudix adopts a fold that is unique for the Nudix protein superfamily. It contains a mixed five-strand β-sheet (comprised of β10, β11, β6, β7, β12) that is split in the middle between β6 and β7 with the insertion of two additional short strands β8 and β9 (Fig. 3A). Two α helices packed on each side of the sheet. The substrate ADPR binds near the split of the central β sheet, between strands β8, β9, helix α9 and the C-terminal end of helix α8 that connects the two domains (Fig. 3A). The Nudix signature motif, or “Nudix-box”, encompasses the structural elements β9-loop-α9 and intimately interacts with the bound substrate.
While the overall structure of the ADPRase domain of NadM-Nudix is similar to the Nudix core domain of the monofunctional bacterial ADPRase exemplified by E. coli ADPRase (ecADPRase, Orf 209) with an average rmsd of 2.8Å over 124 superimposed Cα atoms, NadM-ADPRase lacks the N-terminal three-strand β-sheet domain that are conserved in the monofunctional bacterial ADPRases (Gabelli et al., 2002; Kang et al., 2003; Yoshiba et al., 2004) (Fig. 5). Instead the connector helix α8 of NadM-Nudix partially occupies the position corresponding to this β-sheet domain. Because this β-sheet domain of ecADPRase contributes to the dimerization of the enzyme through extensive domain swapping, lack of this domain in NadM-Nudix leads to a very different dimer interface (Fig 3B and Fig. 5). The primary contact between the two subunits of bacterial NadM-Nudix dimer is formed through their ADPRase domains, between the C-terminal end of connector helix α8 and the succeeding loop from each subunit (Fig. 3B). This loop, connecting α8 and strand β6, protrudes into the substrate-binding site of the second subunit of the dimer and specifically interacts with the bound substrate in the second active site (see below).
Figure 5
Figure 5
Different dimerization modes in NadM-ADPRase and E. coli ADPRase
ADP-ribose binding
Surprisingly, syNadM-Nudix is co-purified and co-crystallized with a bound ADPR substrate as revealed in the unambiguous electron density for ADPR (Fig. 2B). Understandably, the enzyme might not be active during the purification process since the required divalent metal ion was not present in buffers. It is however not clear why ADPR is not hydrolyzed by the enzyme in the cell. The intrinsic high affinity of syNadM-Nudix for ADPR, the low ADPRase activity of the enzyme (Raffaelli, et al., 1999a), and the presence of a substantial ADPR pool in E. coli (data not shown) may contribute to the retention of the substrate in its active site.
The bound ADPR molecule is shaped like a saddle and interacts with protein residues extensively, especially through the terminal ribose and the adenine base (Fig. 6A). Remarkably, every functional group of the terminal ribose is involved in specific hydrogen bond interactions with the enzyme (Fig. 6A): the O4’ of the ribose interacts with the side chain of Arg280, O1’ with Arg277 and Glu326, O2’ with His 328, Arg 277 and Asp205, and O3’ with Asp 205. On the other end of the substrate, the adenine ring is tightly sandwiched between Phe234 and Tyr197B from the second monomer of the dimer. A specific hydrogen bond is formed between the side chain of Tyr188 and N7 of the adenine, while the N1 and N6 groups interact with the enzyme indirectly through two water molecules (not shown). The direct interactions between the enzyme and the diphosphate moiety of ADPR are less extensive in this complex. The β phosphate interacts with Arg219 directly, and with Arg280 and Glu252 indirectly through two water molecules (Fig. 6A). The adenylyl phosphate (α phosphate) is surrounded by several acidic residues from the Nudix-motif, including Glu 248, Glu 251, Glu252, as well as Arg 247. It is possible that some of the acidic glutamate side chains may be protonated. Specific hydrogen bonds are formed between α phosphate oxygens with main chain amide of Phe234 (also part of the Nudix-motif), and with two water molecules that are coordinated by Arg 247, Glu248 and Glu 251 (Fig. 6A). There are essentially no specific direct interactions between protein and the adenosyl ribose group. Hence ADPR derivatives modified at this ribose, such as the NADP degradation product 2’-phospho-ADPR, is also a good substrate for the enzyme (Raffaelli et al., 1999a).
Figure 6
Figure 6
Figure 6
Recognition of ADP-ribose substrate by the ADPRase domain of NadM-Nudix
The substrate-binding mode of NadM-ADPRase turns out to be significantly different from that of ecADPRase especially in the adenosine and terminal ribose portions of the substrate. (Fig. 6B). When the active site residues of the two enzymes are superimposed, the bound ADPR substrates in the two proteins overlap only at the α and β phosphate positions, with the adenosine and terminal ribose oriented differently with regard to the central diphosphate and interacting with completely different sets of protein residues (Fig. 6B). In particular, residues from the swapped N-terminal three-strand β sheet domain of ecADPRase are involved in substrate binding, while this domain is absent in NadM-ADPRase and is partially replaced by a helical segment of the same subunit. Nevertheless, the protein residues surrounding the diphosphate moiety, mostly residues from the Nudix motif, remain conserved in sequence and structure, suggesting that these two enzymes still share substantial common features in catalytic mechanism (discussed later).
In contrast to ecADPRase, the substrate-binding site of NadM-ADPRase exhibits significant similarity to human NUDT9 protein, a human Nudix enzyme highly specific for ADP-ribose (Perraud et al., 2003; Shen et al., 2003). The structure of human NUDT9 in complex with product ribose 5-phosphate (R5P) is available (Shen et al., 2003). The position and orientation of the bound R5P in NUDT9 superimpose relatively well with the corresponding portion of the bound ADPR in syNadM-Nudix (Fig. 6C). The protein conformations surrounding the substrate in the two structures are also very similar. Four out of five residues that specifically interact with the terminal ribose are conserved in both structures. These include Asp172, Arg204, Arg 273 and His324 of NUDT9, corresponding to Asp205, Arg219, Arg280 and His328 of syNadM-Nudix, respectively (Fig. 6C). Only Arg277 of syNadM-Nudix is not conserved in NUDT9. Currently, no experimentally determined structure of NUDT9-substrate complex is available. Superposition of syNadM-ADPRase domain with NUDT9 brings the syNadM-Nudix bound ADP-ribose into NUDT9 active site without any steric clashes, thus affords a model for substrate binding in NUDT9 (Fig. 6C). In this model, the adenine ring would be sandwiched between Trp110 and Met216 of NUDT9, and the N6 group of adenine would interact with the side chain of Asn168. Remarkably, this model, obtained through superposition with NadM-ADPRase domain, appears to be very similar to a previously described model obtained by manual docking and energy minimization, particularly in the conformation of the adenosine portion of the substrate (Shen et al., 2003). The described protein-substrate interactions in the previous model are essentially the same as observed in the present work.
Structure of ftNadM-Nudix complexed with AMP and metal ions
The difference anomalous electron density map calculated from a Mn2+ soaked ftNadM-Nudix crystal revealed unambiguously the positions of three Mn2+ ions (Fig. 2C). They are coordinated directly to the Nudix motif residues Gly234, Glu250 and Glu254 (F. tularensis enzyme numbering), to Asp308 from the so-called “L9 loop” (Gabelli et al., 2001; Gabelli et al., 2002), and to the two oxygen atoms from AMP phosphate (Fig. 7A). While Glu250 is ligated to both Mn1 and Mn2, Glu254 and Asp308 each also coordinates two metal ions, Mn2 and Mn3. A total of seven water molecules complete the rest of the coordination spheres for the three metal ions. Overall, all three metal ions have good octahedral coordination configurations. The metal coordinating water molecules are further hydrogen-bonded to Glu238, Arg249 and Glu253 of the Nudix motif, to Asp307 of L9 loop, and to Arg221 from strand β7. In particular, one water molecule (w1), or more likely a hydroxide ion bridging Mn1 and Mn2, is further ligated to Asp307 and strategically located about 3.2Å away from the α phosphorus of the bound nucleotide, ideally suited for a nucleophilic attack on the α phosphorus of the substrate to initiate the hydrolysis between α and β phosphates (Fig. 7A).
Figure 7
Figure 7
Metal ion binding in ADPRase domain of NadM-Nudix
Comparing the metal free substrate complex of syNadM-Nudix with metal bound ftNadM-Nudix, the most notable structural difference is in the conformation of the L9 loop (residues 302–314, ftNadM-Nudix numbering), which contains two catalytically important Asp residues (Asp307 and Asp308,) (Fig. 7B). In the metal free syNadM-Nudix structure, this loop is highly flexible and is disordered in two of the three monomers in the asymmetric unit. In the third monomer, this loop adopts a more open conformation compared to that in the metal bound ftNadM-Nudix structure (Fig. 7B). It appears that metal binding causes the reorientation and stabilization of this loop through the two Asp residues at the tip of the loop that are now intimately involved in metal binding and likely participate in catalysis. The metal and substrate binding induced conformational change of L9 loop has also been observed in the structures of ADPRase from E. coli and M. tuberculosis but not in T. thermophilus ADPRase (Gabelli et al., 2002; Kang et al., 2003; Yoshiba et al., 2004). The two Glu residues at the tip of this loop in ecADPRase, Glu162 and Glu164, have been shown to be critical catalytic residues, with Glu164 coordinating the catalytic metal ions and Glu162 acting as a catalytic base (Gabelli et al., 2002). In human NUDT9, a double mutation of Asp304 and Asp305, corresponding to Asp307 and Asp308 of ftNadM-Nudix, to alanines resulted in a reduction of catalytic efficiency to about 1/100 of the wild-type enzyme (Shen et al., 2003), suggesting that these two Asp residues are indeed important for catalysis, though they might not be absolutely indispensable for NUDT9.
Proposed catalytic mechanisms for NadM-ADPRase
Superposition of ftNadM-Nudix·Mn·AMP with syNadM-Nudix·ADPR complex structures revealed that the product AMP bound to ftNadM-Nudix overlaps closely with the adenosyl moiety of the bound substrate ADPR in syNadM-Nudix (Fig. 7B). It is likely that metal ions in the substrate bound NadM-Nudix complex would occupy the same positions as in the product complex structure. More significantly, when superimposed with the structure of ecADPRase complexed with AMPCPR, a non-hydrolysable ADP-ribose analog, the three metal ions and the bridging water w1 in ftNadM-Nudix overlay nearly perfectly with the corresponding atoms in the ecADPRase complex (Fig. 6B). Most Nudix motif residues, G234, E238, R249, E250, E253, and E254 (F. tularensis enzyme numbering) also superimpose well between the two enzymes (Fig. 6B). The other two catalytic residues, E162 and E164 from ecADPRase are positioned differently from the corresponding residues D307 and D308 of ftNadM-Nudix, and yet they appear to perform similar roles in coordinating metal ions and the catalytic water molecule w1. The similarity in the catalytic site configuration immediately suggests that ADPRase of NadM-Nudix should have a similar catalytic mechanism as that of ecADPRase despite a very different substrate recognition mode. Here, Asp307 may perform a similar role as Glu162 in ecADPRase, i.e., to function as a catalytic base activating the metal-bound water (w1) for nucleophilic attack on the adenosyl phosphate.
The similar catalytic mechanism and different substrate recognition mode between NadM-ADPRase and ecADPRase forms an interesting contrast to that of ADPRase from Thermus thermophilus (ttADPRase) (Yoshiba et al., 2004). ttADPRase is a member of bacterial monofunctional ADPRase subfamily and its structure closely resembles ecADPRase. In addition to the Nudix core domain, ttADPRase also contains an N-terminal three strand β-sheet domain that contributes to substrate binding and formation of a similar dimer as ecADPRase. However, the L4 loop of ttADPRase, corresponding to the L9 loop of ecADPRase, adopts a very different conformation and does not undergo conformational changes upon metal/substrate binding. Although the two Glu residues at the tip of the loop are conserved in both ttADPRase and ecADPRase sequences (Fig. 8), in ttADPRase they are located further away from the active site and do not participate in either metal ion coordination or catalysis as demonstrated by mutational analysis (Yoshiba et al., 2004). In contrast to that observed in NadM-ADPRase, the substrate ADP-ribose binds to ttADPRase active site in a conformation that is similar to the ecADPRase bound substrate in the adenosine and terminal ribose moieties, but substantially different in the central diphosphate group. The metal ion positions in ttADPRase are also drastically different from those in ecADPRase. All these structural observations support a different catalytic mechanism for ttADPRase (Yoshiba et al., 2004).
Figure 8
Figure 8
Multiple sequence alignment of representative ADPRases
Function of NadM-Nudix in bacterial NAD metabolism
The present study fills in the last gap in the structural coverage of the divergent pyridine adenylyltransferase family involved in the last steps of NAD synthesis from its mononucleotide precursors NaMN and/or NMN (Fig. 1). Comparative genomic reconstruction of NAD metabolism in ~ 400 completely sequenced bacterial genomes integrated within the SEED database (Overbeek et al., 2005)(“NAD and NADP cofactor biosynthesis global” susbsystem spreadsheet available at http://anno-3.nmpdr.org/anno/FIG/subsys.cgi) indicates that the major role of bacterial NadM homologs is likely in a two-step non-deamidating pathway of recycling nicotinamide released by a glycohydrolytic degradation of NAD or/and NADP (Fig. 1B). This conjecture is supported by the following observations: (i) in contrast to the biosynthetic NaMNATase of NadD family conserved in the overwhelming majority of bacterial genomes, NadM homologs are present only in ~ 20 genomes of diverse bacteria (see Supplementary Table 1); (ii) in most of these genomes (with an exception of F. tularensis and two species of Deinococcus), NadM is present in addition to (and not instead of) the housekeeping NadD; (iii) in this subset of genomes (with a single exception of Gloebacter violaceus), NadM homologs are encoded within a conserved operon with genes encoding nicotinamide phosphoribosyltransferase (NadV), suggesting their participation in a two-step conversion of nicotinamide to NAD via NMN intermediate; (iv) all bacterial NadM homologs (with a single exception of Acinetobacter sp.) occur as fusion proteins with a Nudix domain that hydrolyzes ADP-ribose, the second product of NAD glycohydrolytic cleavage reactions releasing nicotinamide (Fig. 1); (v) both products of ADPRase reaction, AMP and ribose-5-phosphate, can be further converted to ATP and phosphoribose pyrophosphate (PRPP), metabolites required for NAD synthesis as well as many other metabolic pathways; (vi) a noted presence of both genes encoding NadV and NadM-Nudix in the genomes of several T4-like bacteriophages (Miller et al., 2003), alludes to the importance of NAD recycling for bacteriophage development and supports a likely role of horizontal gene transfer in the propagation of these genes in bacterial genomes (S. Gerdes, personal communication). More importantly, results from the gene inactivation experiments done with Synechocystis sp. nadV-nadM (slr0788-slr0787) are in full agreement with the above proposed role for bacterial NadM (Gerdes et al., 2006). It should be noted that although the processes of NAD degradation that generate nicotinamide and ADP-ribose has been known for many years (Pollack et al., 2007), current knowledge on enzymes involved in these processes is rather sparse. Genes encoding such enzymes are "missing" in many bacterial species, including Synechocystis sp. and F. tularensis.
Although, in principle, a two-step conversion of nicotinamide to NAD may contribute to both recycling of endogenous and salvage of exogenous nicotinamide, the latter pathway was ruled out by the experiments in Synechocystis sp. model (Gerdes et al., 2006). So far, all known bacterial genomes harboring both NadM-Nudix and NadD contain a full complement of genes for de novo NAD biosynthesis from aspartate (as in some Burkholderiales and Cyanobacteria) or from tryptophan (as in some Xanthomonadales), and some of them carry out additional nicotinate and nicotinamide riboside salvage routes (see Supplementary Table S1). This observation, together with other considerations listed above, argues in favor of the main role of NadV- NadM-Nudix pathway in NAD recycling.
Reconstruction of NAD metabolism in F. tularensis reveals a remarkable example of adaptive evolution where the NMNATase activity of a peripheral recycling/salvage enzyme (NadM) was recruited to compensate for the lack of NadD in the main route of NAD cofactor biosynthesis. This adaptation included evolution of a novel enzymatic activity, NMN synthetase (EC. 6.3.1.-), which amidates NaMN to NMN prior to its adenylation by NadM (Fig. 1B. Sorci et al., submitted). This novel activity is performed by a divergent member of NadE family of NAD synthetases (EC 6.3.1.5) whose role in most other species is to amidate NaAD intermediate generated by NaMNATase.
Another special case is observed in Deinococcus geothermalis and Deinococcus radiodurans, the only genomes, beyond F. tularensis, where NadM-Nudix homologs have replaced NadD enzyme. Interestingly, each of these genomes contains two NadM-Nudix paralogs. The multiple sequence alignment analysis shows that one of these paralogs (eg DR2428 in Deinococcus radiodurans) is closely related to other bacterial enzymes of NadM-Nudix subfamily, whereas the second paralog (DRA0273) is substantially more divergent (Supplementary Fig. S1). Moreover, in the second paralog, the “pyridine recognition loop” region appears to be more similar to archaeal NadM and contains a one amino acid deletion compared to bacterial NadM (Supplemental Fig. S1). Therefore DRA0273 may have a similar substrate preference as archaeal NadM and be able to accept a deamidated mononucleotide substrate. This speculation is additionally supported by the chromosomal clustering of DRA0273 (as well as its ortholog in D. geothermalis) with nicotinate phosphoribosyltransferase (EC 2.4.2.11), the enzyme converting nicotinic acid to NaMN in the regular salvage pathway. These observations, along with the apparent presence of a regular NAD synthetase (rather than NMN synthetase as in F. tularensis) suggest that, in contrast to all other bacterial NadM-Nudix enzymes, DRA0273 may play a role of NaMNATase in the conventional NaMN→NMN→NAD pathway associated with the salvage of nicotinic acid. The first paralog, DR2428, on the other hand, is likely involved in the nondeamidating recycling/salvage of nicotinamide, together with NadV homolog (DR0294). The role of the respective NadM-Nudix paralog in D. geothermalis is less clear, as this genome does not contain NadV, whereas, unlike D. radiodurans, it contains an entire set of genes for the de novo NAD biosynthesis from aspartate (Supplementary Table S1).
Implications for human NUDT9 and the ADPR-gating domain of TRPM2 channel
Structure and sequence comparison of the ADPRase domain of bacterial NadM-Nudix with other members of the Nudix superfamily showed that NadM-ADPRase is more closely related to archaeal ADPRase and human NUDT9 than to the monofunctional bacterial ADPRases (Fig. 8). Given that the NMNATase domain of bacterial NadM-Nudix also has an archaeal origin, it is not surprising that its ADPRase domain should be of archaeal origin as well. Results from sequence alignment and structure superposition with human NUDT9 revealed that most residues in NadM-ADPRase that interact with ADPR substrate and catalytic metal ions are conserved in NUDT9, suggesting that NUDT9 is likely to have a similar substrate binding mode as NadM-ADPRase, which is significantly different from that observed in E. coli ADPRase. Because of the close relationship between human NUDT9 and the C-terminal cytoplasmic Nudix domain of ADPR-gated Ca2+ channel TRPM2, it is tempting to speculate that the Nudix-domain of TRPM2 may also employ a similar ADPR binding mode as that of NUDT9 and NADM-ADPRase. Indeed, two of the four residues in NadM-ADPRase that anchor the terminal ribose group of the substrate, Arg 280 and His326, are strictly conserved in TRPM2 (Arg 1433 and His1488 of human TRPM2, respectively) (Fig. 8), while the other two interacting residues, Asp205 and Arg277 of syNadM-Nudix, are aligned with Tyr1349 and Asp1430 of human TRPM2, respectively, which are also able to form hydrogen bonds with hydroxyl groups of the ribose. Notably, the Nudix-box sequence of TRPM2 channel is deteriorated and lacks two critical Glu residues (Fig. 8), resulting in a much reduced ADPRase activity (Perraud et al., 2001). Because of the differences in the metal binding residues of the Nudix-box motif and in the region corresponding to L9 loop, the ligand binding induced conformational changes in TRPM2 channel may be different from that observed in NUDT9, NadM-ADPRase and other ADPRases.
In summary, we have determined the crystal structures of two representatives of bacterial NadM-Nudix family, one from a model cyanobacterium Synechocystis sp. and the other from a biodefense pathogen F. tularensis. These two enzymes, each comprised of two functional domains, NMNATase and ADPRase, are closely related in sequence and structure but distinct in their cellular functions. The combined sequence and structure analysis points to an archaeal origin for both domains of bacterial NadM-Nudix proteins. Due to the unique essential role of F. tularensis NadM-Nudix protein in NAD cofactor synthesis (Sorci et al. submitted), the delineation of its three dimensional structure should facilitate a structure-based drug design effort aimed at developing novel anti-infectious agents against this deadly pathogen. The structures of NadM-Nudix proteins in complex with substrate, metal ions and products associated with their ADPRase domains shed new light into catalysis and substrate recognition mechanisms that are likely shared with human NUDT9 ADPRase and the NUDT9-like domain of ADPR-gated Ca2+ channel TRAM2.
Expression and Purification of syNadM-Nudix and ftNadM-Nudix
Expression vector containing open reading frame slr0787 encoding syNadM-Nudix was previously constructed by Raffaelli et al. (Raffaelli et al.,1999a). For structural analysis, the insert was subcloned into a pPROEX vector (Invitrogene, Carlsbad, CA) and transformed into E. coli stain BL21(DE3) for protein expression. The cells were induced by adding 0.8 mM IPTG when OD600 reached 0.6 and harvested after shaking at 20 ºC overnight. The clarified cell lysate was mixed with the appropriate amount of nickel-nitrilotriacetic acid (NTA) – agarose beads (Qiagen, Valencia, CA) and incubated at 4 °C for 1 hr. After extensive washing, the bound protein was eluted with 50 mM Tris, pH 8.0, 300mM NaCl and 250mM imidazole. The protein was then treated with TEV protease at 4 ºC overnight to cleave the 6xHis tag. The tag free protein was further purified with a Mono Q ion exchange column (GE Healthcare Bio-Sciences, Piscataway, NJ) and eluted with a gradient of NaCl. Gel-filtration column Superdex 75 (GE Healthcare Bio-Sciences, Piscataway, NJ) was used as the last purification step with a buffer containing 20mM Tris pH 8.0, 150 mM NaCl and 1mM DTT. The selenomethionyl syNadM-Nudix was expressed in minimal medium supplemented with selenomethionine and other nutrients as described in Doublie, 1997, and purified using the same procedure as the native protein.
The gene encoding ftNadM-Nudix was originally cloned into the vector pODC29 (Sorci et al. submitted). In order to increase the yield of protein for crystallographic analysis, the insert was subcloned into the vector pGST-parallel1 (Sheffield et al., 1999). Transformation and expression of ftNadM-Nudix followed the same procedure as syNadM-Nudix. Cell pellets were suspended in the phosphate buffered saline (PBS) (Sigma, St. Louis, MO) and lysed by sonication. The clarified cell lysate was mixed with appropriate amount of Glutathione Sepharose 4B beads (GE Healthcare Life Sciences) and incubated at 4ºC for 1 hr. After washing thoroughly with PBS buffer, the protein-bound beads were treated with TEV protease at 4 ºC overnight and the tag-cleaved protein was eluted with PBS buffer. The protein was then loaded on a Mono Q ion exchange column buffered with 50mM Tris, pH8.0 and eluted with a gradient of NaCl.
Enzyme activity assays
NaMNAT and NMNAT activities were measured using coupled spectrophotometric assays as previously described (Kurnasov et al. 2002). The Nudix hydrolase activity was measured by an HPLC-based assay. The reaction, in a mixture of 50 mM HEPES, pH 8.2, 5 mM MgCl2, 10–40 ng recombinant NadM in 100 μl volume, was initiated by addition of ADP-ribose to 0.01–2 mM range and incubated for 15 min at 37 ºC. Other biochemicals (NAD+, NaAD+, NADH, NADP+, NADPH, cyclic-ADPR, ADP-glucose, ADPR-ribose, Ap2A, ATP, ADP, and dNTPs) were tested as potential substrates at 1 mM.
Due to a substantial metal-ion catalyzed decomposition of nucleoside diphosphate sugars (Nunez and Barker, 1976), measurements of AMP product were adjusted by parallel processing of controls without the enzyme. When testing reduced pyridine nucleotides as the substrates, reactions were stopped by boiling for three minutes. For the other nucleoside diphosphate derivatives, reactions were terminated and products analyzed by HPLC following the protocol described in Sorci et al. (submitted) with minor modifications with regard to column (Shimadzu C18, 4.6 x 50mm, 5 μM pore size) and gradient system. The elution conditions were 2 min at 95% buffer A (8 mM tetrabutylammonium bromide in 0.1 M potassium phosphate, pH 6.0), 3 min up to 100% buffer B (30% methanol), holding at 100% buffer B for 2.5 min. After returning the gradient to 100% buffer A in 0.5 min, the column was flushed with buffer A for 1.5 min prior to the next run. Km and kcat values were calculated by fitting initial rates to the integrated Michaelis-Menten equation with the software Prism 4 (GraphPad).
Crystallization and Data Collection
Crystallization of syNadM-Nudix was performed using hanging drop vapor diffusion method. 1.5 μl of syNadM-Nudix protein (15mg/ml) was mixed with 1.5 μl of reservoir solution containing 100mM Tris, pH 7.5, and 1.5 M Li2SO4, and equilibrated against the reservoir at 20 ºC. Single crystals usually appeared within 3 days and grew to a final size of about 0.5x0.3x0.3mm3 within two weeks.
FtNadM-Nudix crystals were grown at 20ºC using sitting drop vapor diffusion method. 1 μl of ftNadM-Nudix protein (15mg/ml) was mixed with an equal volume of the reservoir solution containing 0.1 M Tris, pH 7.5, 200 mM MgCl2, and 19% PEG3350, and equilibrated against the reservoir. To obtain the ftNadM-Nudix-AMP complex crystals, ftNadM-Nudix was mixed with 30 mM (final concentration) nucleotide before crystallization.
For data collection, crystals were transferred stepwise to a cryoprotection solution containing the original reservoir solution and additional 30% glycerol. For Mn2+ soaked ftNadM-Nudix-AMP complex crystal, cryoprotection solution included 200mM MnCl2 instead of 200mM MgCl2. Native and SeMet MAD data sets from syNadM-Nudix crystals were collected at beamline 19BM of Advance Photon Source, Argonne National Laboratory (Argonne, IL.). ftNadM-Nudix data sets were collected in-house on a RAXIS-IV++ image plate detector equipped with a Rigaku FR-E SuperBright X-ray generator and VarimaxTM HF mirrors.
Diffraction data were processed with DENZO and SCALEPACK (Otwinowski and Minor, 1997). The syNadM-Nudix crystals belong to space group P3221 with unit cell parameters a = b = 201.5Å, c = 98.7Å, γ = 120°. ftNadM-Nudix was crystallized in space group F222 with unit cell parameters a = 125.6Å, b = 163.6Å, c = 180.0Å. The statistics of all data sets are listed in Table 2
Table 2
Table 2
Crystal Data and refinement statistics
Phasing and refinement
The initial phases of syNadM-Nudix structure were determined using multiwavelength anomalous dispersion (MAD) phasing method with data collected at three different wavelengths from a SeMet syNadM-Nudix crystal. The Se site determination, phasing, and density modification were performed using program SHELX/C/D/E (Schneider and Sheldrick, 2002; Sheldrick, 2002) modules in the CCP4 package (CCP4, 1994), which resulted in a clearly interpretable electron density map. The model of syNadM-Nudix was built using Arp/warp (Perrakis et al., 1999; Perrakis et al., 1997) and COOT (Emsley and Cowtan, 2004). Refinement of the model was performed with simulated annealing refinement protocol in PHENIX suite (Adams et al., 2004) and Refmac (Murshudov et al., 1997) monitoring Rwork and Rfree. The final model includes three syNadM-Nudix monomers, each contain 344 residues, one NAD and one ADP-ribose molecules. A total of 313 water molecules are also included in the model.
The structure of ftNadM-Nudix was determined by molecular replacement method with program Phaser (McCoy et al., 2005) using syNadM-Nudix monomer as the searching model. Model building and refinement was done following similar procedures as that for syNadM-Nudix. The final model for ftNadM-Nudix contains two protein monomers, each associated with three Mg ions. The ftNadM-Nudix-AMP complex model also contains two AMP molecules in addition to the metal ions.
Accession numbers
The coordinates and structure factors for ftNadM-Nudix and syNadM-Nudix have been deposited in Protein Data Bank (2QJO for syNadM-Nudix complex; 2R5W and 2QJT for ftNadM-Nudix·Mg and ftNadM-Nudix·AMP·Mn2+ complexes, respectively).
Supplementary Material
Acknowledgments
We thank Darek Martynowski for help with crystallography experiments, Jimin Pei and Lisa Kinch for help with protein sequence analysis. F. tularensis subsp. Holarctica LVS genomic DNA was a kind gift from Karl E. Klose (University of Texas, San Antonio). This work was supported by NIH grant GM65243 (to H.Z), AI059146 (to A.O.) and a Welch Foundation Grant I-1505 (to NVG). Use of Argonne National Laboratory Structure Biology Center beamline at Advanced Photon Source was supported by the U.S. Department of Energy, Office of Biological and Environmental Research, under contract No. W-31-109-ENG-38.
Footnotes
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
  • Collaborative Computational Project Number 4. The CCP4 Suite: programs for protein crystallography. Acta Crystallogr D. 1994;50:760–763. [PubMed]
  • Adams PD, Gopal K, Grosse-Kunstleve RW, Hung LW, Ioerger TR, McCoy AJ, Moriarty NW, Pai RK, Read RJ, Romo TD, et al. Recent developments in the PHENIX software for automated crystallographic structure determination. J Synchrotron Radiat. 2004;11:53–55. [PubMed]
  • Begley TP, Kinsland C, Mehl RA, Osterman A, Dorrestein P. The biosynthesis of nicotinamide adenine dinucleotides in bacteria. Vitam Horm. 2001;61:103–119. [PubMed]
  • Berger F, Lau C, Dahlmann M, Ziegler M. Subcellular compartmentation and differential catalytic properties of thethree human nicotinamide mononucleotide adenylyltransferase isoforms. J Biol Chem. 2005;280:36334–36341. [PubMed]
  • Bessman MJ, Frick DN, O'Handley SF. The MutT proteins or "Nudix" hydrolases, a family of versatile, widely distributed, "housecleaning" enzymes. J Biol Chem. 1996;271:25059–25062. [PubMed]
  • Bork P, Holm L, Koonin EV, Sander C. The cytidylyltransferase superfamily: identification of the nucleotide-binding site and fold prediction. Proteins. 1995;22:259–266. [PubMed]
  • Burkle A. Poly(APD-ribosyl)ation, a DNA damage-driven protein modification and regulator of genomic instability. Cancer Lett. 2001;163:1–5. [PubMed]
  • D'Angelo I, Raffaelli N, Dabusti V, Lorenzi T, Magni G, Rizzi M. Structure of nicotinamide mononucleotide adenylyltransferase: a key enzyme in NAD(+) biosynthesis. Structure Fold Des. 2000;8:993–1004. [PubMed]
  • Denu JM. The Sir 2 family of protein deacetylases. Curr Opin Chem Biol. 2005;9:431–440. [PubMed]
  • Doublie S. Preparation of selenomethionyl proteins for phase determination. Methods Enzymol. 1997;276:523–530. [PubMed]
  • Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60:2126–2132. [PubMed]
  • Foster JW, Park YK, Penfound T, Fenger T, Spector MP. Regulation of NAD metabolism in Salmonella typhimurium: molecular sequence analysis of the bifunctional nadR regulator and the nadA-pnuC operon. J Bacteriol. 1990;172:4187–4196. [PMC free article] [PubMed]
  • Gabelli SB, Bianchet MA, Bessman MJ, Amzel LM. The structure of ADP-ribose pyrophosphatase reveals the structural basis for the versatility of the Nudix family. Nat Struct Biol. 2001;8:467–472. [PubMed]
  • Gabelli SB, Bianchet MA, Ohnishi Y, Ichikawa Y, Bessman MJ, Amzel LM. Mechanism of the Escherichia coli ADP-ribose pyrophosphatase, a Nudix hydrolase. Biochemistry. 2002;41:9279–9285. [PubMed]
  • Garavaglia S, D'Angelo I, Emanuelli M, Carnevali F, Pierella F, Magni G, Rizzi M. Structure of human NMN adenylyltransferase. A key nuclear enzyme for NAD homeostasis. J Biol Chem. 2002;277:8524–8530. [PubMed]
  • Gerdes SY, Kurnasov OV, Shatalin K, Polanuyer B, Sloutsky R, Vonstein V, Overbeek R, Osterman AL. Comparative genomics of NAD biosynthesis in cyanobacteria. J Bacteriol. 2006;188:3012–3023. [PMC free article] [PubMed]
  • Gerdes SY, Scholle MD, D'Souza M, Bernal A, Baev MV, Farrell M, Kurnasov OV, Daugherty MD, Mseeh F, Polanuyer BM, et al. From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways. J Bacteriol. 2002;184:4555–4572. [PMC free article] [PubMed]
  • Han S, Forman MD, Loulakis P, Rosner MH, Xie Z, Wang H, Danley DE, Yuan W, Schafer J, Xu Z. Crystal structure of nicotinic acid mononucleotide adenylyltransferase from Staphyloccocus aureus: structural basis for NaAD interaction in functional dimer. J Mol Biol. 2006;360:814–825. [PubMed]
  • Kang LW, Gabelli SB, Cunningham JE, O'Handley SF, Amzel LM. Structure and mechanism of MT-ADPRase, a nudix hydrolase from Mycobacterium tuberculosis. Structure. 2003;11:1015–1023. [PubMed]
  • Koonin EV. A highly conserved sequence motif defining the family of MutT-related proteins from eubacteria, eukaryotes and viruses. Nucleic Acids Res. 1993;21:4847. [PMC free article] [PubMed]
  • Kurnasov OV, Polanuyer BM, Ananta S, Sloutsky R, Tam A, Gerdes SY, Osterman AL. Ribosylnicotinamide kinase domain of NadR protein: identification and implications in NAD biosynthesis. J Bacteriol. 2002;184:6906–6917. [PMC free article] [PubMed]
  • Landry J, Sutton A, Tafrov ST, Heller RC, Stebbins J, Pillus L, Sternglanz R. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc Natl Acad Sci U S A. 2000;97:5807–5811. [PubMed]
  • Magni G, Amici A, Emanuelli M, Orsomando G, Raffaelli N, Ruggieri S. Structure and function of nicotinamide mononucleotide adenylyltransferase. Curr Med Chem. 2004;11:873–885. [PubMed]
  • Magni G, Amici A, Emanuelli M, Raffaelli N, Ruggieri S. Enzymology of NAD+ synthesis. Adv Enzymol Relat Areas Mol Biol. 1999;73:135–182. xi. [PubMed]
  • McCoy AJ, Grosse-Kunstleve RW, Storoni LC, Read RJ. Likelihood- enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr. 2005;61:458–464. [PubMed]
  • McLennan AG. The Nudix hydrolase superfamily. Cell Mol Life Sci. 2006;63:123–143. [PubMed]
  • Mildvan AS, Xia Z, Azurmendi HF, Saraswat V, Legler PM, Massiah MA, Gabelli SB, Bianchet MA, Kang LW, Amzel LM. Structures and mechanisms of Nudix hydrolases. Arch Biochem Biophys. 2005;433:129–143. [PubMed]
  • Miller ES, Kutter E, Mosig G, Arisaka F, Kunisawa T, Ruger W. Bacteriophage T4 genome. Microbiol Mol Biol Rev. 2003;67:86–156. table of contents. [PMC free article] [PubMed]
  • Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. 1997;D53:240–255.
  • Nunez HA, Barker R. The metal ion catalyzed decomposition of nucleoside diphosphate sugars. Biochemistry. 1976;15:3843–3847. [PubMed]
  • Olland AM, Underwood KW, Czerwinski RM, Lo MC, Aulabaugh A, Bard J, Stahl ML, Somers WS, Sullivan FX, Chopra R. Identification, characterization, and crystal structure of Bacillus subtilis nicotinic acid mononucleotide adenylyltransferase. J Biol Chem. 2002;277:3698–3707. [PubMed]
  • Osterman AL, Begley TP. A subsystems-based approach to the identification of drug targets in bacterial pathogens. Prog Drug Res. 2007;64:131, 133–170. [PubMed]
  • Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997;276:307–326.
  • Overbeek R, Begley T, Butler RM, Choudhuri JV, Chuang HY, Cohoon M, de Crecy- Lagard V, Diaz N, Disz T, Edwards R, et al. The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res. 2005;33:5691–5702. [PMC free article] [PubMed]
  • Penfound T, Foster JW. Biosynthesis and Recycling of NAD. In: Neidhardt FC, editor. Escherichia Coli and Salmonella. Washington D.C: AMS Press; 1996. pp. 721–730.
  • Perrakis A, Morris R, Lamzin VS. Automated protein model building combined with iterative structure refinement. Nat Struct Biol. 1999;6:458–463. [PubMed]
  • Perrakis A, Sixma TK, Wilson KS, Lamzin VS. wARP: improvement and extension of crystallographic phases by weighted averaging of multiple refined dummy atomic models. Acta Crystallogr D Biol Crystallogr. 1997;53:448–455. [PubMed]
  • Perraud AL, Fleig A, Dunn CA, Bagley LA, Launay P, Schmitz C, Stokes AJ, Zhu Q, Bessman MJ, Penner R, et al. ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology. Nature. 2001;411:595–599. [PubMed]
  • Perraud AL, Shen B, Dunn CA, Rippe K, Smith MK, Bessman MJ, Stoddard BL, Scharenberg AM. NUDT9, a member of the Nudix hydrolase family, is an evolutionarily conserved mitochondrial ADP-ribose pyrophosphatase. J Biol Chem. 2003;278:1794–1801. [PubMed]
  • Pollack N, Dolle C, Ziegler M. The power to reduce:pyridine nucleotides–small molecules with a multitude of functions. Biochem J. 2007;402:205–218. [PubMed]
  • Raffaelli N, Amici A, Emanuelli M, Ruggieri S, Magni G. Pyridine dinucleotide biosynthesis in archaebacteria: presence of NMN adenylyltransferase in Sulfolobus solfataricus. FEBS Lett. 1994;355:233–236. [PubMed]
  • Raffaelli N, Lorenzi T, Amici A, Emanuelli M, Ruggieri S, Magni G. Synechocystis sp. slr0787 protein is a novel bifunctional enzyme endowed with both nicotinamide mononucleotide adenylyltransferase and 'Nudix' hydrolase activities. FEBS Lett. 1999a;444:222–226. [PubMed]
  • Raffaelli N, Lorenzi T, Mariani PL, Emanuelli M, Amici A, Ruggieri S, Magni G. The Escherichia coli NadR regulator is endowed with nicotinamide mononucleotide adenylyltransferase activity. J Bacteriol. 1999b;181:5509–5511. [PMC free article] [PubMed]
  • Raffaelli N, Pisani FM, Lorenzi T, Emanuelli M, Amici A, Ruggieri S, Magni G. Characterization of nicotinamide mononucleotide adenylyltransferase from thermophilic archaea. J Bacteriol. 1997;179:7718–7723. [PMC free article] [PubMed]
  • Saridakis V, Christendat D, Kimber MS, Dharamsi A, Edwards AM, Pai EF. Insights into ligand binding and catalysis of a central step in NAD+ synthesis: structures of Methanobacterium thermoautotrophicum NMN adenylyltransferase complexes. J Biol Chem. 2001;276:7225–7232. [PubMed]
  • Saridakis V, Pai EF. Mutational, structural, and kinetic studies of the ATP-binding site of Methanobacterium thermoautotrophicum nicotinamide mononucleotide adenylyltransferase. J Biol Chem. 2003;278:34356–34363. [PubMed]
  • Schneider TR, Sheldrick GM. Substructure solution with SHELXD. Acta Crystallogr D Biol Crystallogr. 2002;58:1772–1779. [PubMed]
  • Sheffield P, Garrard S, Derewenda Z. Overcoming expression and purification problems of RhoGDI using a family of "parallel" expression vectors. Protein Expr Purif. 1999;15:34–39. [PubMed]
  • Sheldrick GM. Macromolecular phasing with SHELXE. Zeitschrift Fur Kristallogeaphie. 2002;217:644–650.
  • Shen BW, Perraud AL, Scharenberg A, Stoddard BL. The crystal structure and mutational analysis of human NUDT9. J Mol Biol. 2003;332:385–398. [PubMed]
  • Singh SK, Kurnasov OV, Chen B, Robinson H, Grishin NV, Osterman AL, Zhang H. Crystal structure of Haemophilus influenzae NadR protein. A bifunctional enzyme endowed with NMN adenyltransferase and ribosylnicotinimide kinase activities. J Biol Chem. 2002;277:33291–33299. [PubMed]
  • Sorci L, Cimadamore F, Scotti S, Petrelli R, Cappellacci L, Franchetti P, Orsomando G, Magni G. Initial-Rate Kinetics of Human NMN-Adenylyltransferases: Substrate and Metal Ion Specificity, Inhibition by Products and Multisubstrate Analogues, and Isozyme Contributions to NAD(+) Biosynthesis. Biochemistry. 2007;46:4912–4922. [PubMed]
  • Tsang AW, Escalante-Semerena JC. CobB, a new member of the SIR2 family of eucaryotic regulatory proteins, is required to compensate for the lack of nicotinate mononucleotide:5,6-dimethylbenzimidazole phosphoribosyltransferase activity in cobT mutants during cobalamin biosynthesis in Salmonella typhimurium LT2. J Biol Chem. 1998;273:31788–31794. [PubMed]
  • Velu SE, Cristofoli WA, Garcia GJ, Brouillette CG, Pierson MC, Luan CH, DeLucas LJ, Brouillette WJ. Tethered dimers as NAD synthetase inhibitors with antibacterial activity. J Med Chem. 2003;46:3371–3381. [PubMed]
  • Werner E, Ziegler M, Lerner F, Schweiger M, Heinemann U. Crystal structure of human nicotinamide mononucleotide adenylyltransferase in complex with NMN. FEBS Lett. 2002;516:239–244. [PubMed]
  • Wilkinson A, Day J, Bowater R. Bacterial DNA ligases. Mol Microbiol. 2001;40:1241–1248. [PubMed]
  • Xu W, Shen J, Dunn CA, Desai S, Bessman MJ. The Nudix hydrolases of Deinococcus radiodurans. Mol Microbiol. 2001;39:286–290. [PubMed]
  • Yoon HJ, Kim HL, Mikami B, Suh SW. Crystal structure of nicotinic acid mononucleotide adenylyltransferase from Pseudomonas aeruginosa in its Apo and substrate-complexed forms reveals a fully open conformation. J Mol Biol. 2005;351:258–265. [PubMed]
  • Yoshiba S, Ooga T, Nakagawa N, Shibata T, Inoue Y, Yokoyama S, Kuramitsu S, Masui R. Structural insights into the Thermus thermophilus ADP-ribose pyrophosphatase mechanism via crystal structures with the bound substrate and metal. J Biol Chem. 2004;279:37163–37174. [PubMed]
  • Zha M, Zhong C, Peng Y, Hu H, Ding J. Crystal structures of human NUDT5 reveal insights into the structural basis of the substrate specificity. J Mol Biol. 2006;364:1021–1033. [PubMed]
  • Zhang H, Zhou T, Kurnasov O, Cheek S, Grishin NV, Osterman A. Crystal structures of E. coli nicotinate mononucleotide adenylyltransferase and its complex with deamido-NAD. Structure (Camb) 2002;10:69–79. [PubMed]
  • Zhang X, Kurnasov OV, Karthikeyan S, Grishin NV, Osterman AL, Zhang H. Structural characterization of a human cytosolic NMN/NaMN adenylyltransferase and implication in human NAD biosynthesis. J Biol Chem. 2003;278:13503–13511. [PubMed]
  • Zhou T, Kurnasov O, Tomchick DR, Binns DD, Grishin NV, Marquez VE, Osterman AL, Zhang H. Structure of human nicotinamide/nicotinic acid mononucleotide adenylyltransferase. Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin. J Biol Chem. 2002;277:13148–13154. [PubMed]